OSTX – os therapies incorporated (US:NASDAQ)
Stock Stats
News
OS Therapies Inc (NYSE: OSTX) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $20.00 price target on the stock.
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma [Yahoo! Finance]
OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma
OS Therapies Inc (NYSE: OSTX) is now covered by analysts at Lake Street Capital. They set a "buy" rating and a $19.00 price target on the stock.
OS Therapies to Host Analyst Day at NYSE on April 7, 2025 [Yahoo! Finance]
Form 8-K OS Therapies Inc For: Mar 31
Form DEFA14A OS Therapies Inc
Form 8-K OS Therapies Inc For: Mar 31
Form 10-K OS Therapies Inc For: Dec 31
Form SCHEDULE 13D/A OS Therapies Inc Filed by: Auerbach Shalom
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.